The C-POST trial showed a disease-free survival benefit with adjuvant Libtayo for high-risk cutaneous squamous cell carcinoma, potentially influencing future standard care. Immunotherapy remains the ...

Skin cancer, a prevalent and potentially life-threatening condition, affects millions of people worldwide. As advancements in medical science continue to evolve, so do the treatment options available ...

Amy A. Vaughan, M.D. Dermatology introduces Gentlecure, the most advanced nonsurgical treatment for nonmelanoma skin cancer, ...

There are three common types of skin cancer in the United States: basal cell carcinoma, squamous cell carcinoma and melanoma. Merkel cell carcinoma is a rare type of skin cancer. Fred Hutch Cancer ...

Live virtual fireside chat — investors, advisors, and life sciences analysts invited to attendFeaturing Dermatologist Mary ...

First U.S. pivotal study for Alpha Tau to have completed enrollment, representing a critical milestone on the path towards potential FDA ...

Doctors at the National Institutes of Health have discovered a new cause of skin cancer, according to a case report published Wednesday in the New England Journal of Medicine. Subscribe to read this ...

As spring turns to summer, May marks Skin Cancer Awareness Month. For my family and me, it’s a time to learn more about the disease, focus on prevention, and understand how early detection can lead to ...

Researchers from China have warned that global skin cancer cases could rise sharply by 2050 due to increasing UV exposure, ...